US medication safety
Saline overwrap, potassium bag: a September 2026 recall
A correct-looking overwrap does not prove what is inside an IV product. A September 2026 Otsuka ICU Medical recall describes a potential mix-up between a 100 mL saline overwrap and potassium chloride within. The case tests identifiers and the ability to interrupt an unsafe administration chain.
Sources checked October 5, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Match identifiers, not appearance
The company announcement of September 17, posted by FDA September 21, describes potassium chloride 10 mEq inside a saline overwrap. The affected saline NDC is 0990-7984-23 and lot 1042188. The potassium product is identified as NDC 0990-7074-26, lot 1035181.
Name, NDC, lot and expiration answer different questions. Size alone does not establish whether an item is affected. Inspect both layers and follow the current notice. Any mismatch needs investigation even if it is not this specific lot.
Keep stock out of the active supply chain
The notice asks customers to check inventory locations, quarantine and discontinue affected product, then follow return instructions. Search relevant storage and distribution points rather than only the shelf where the problem was discovered.
Document identifiers, quantity, location and actions under the institution's process. Quarantine must prevent another person from selecting the product. An informal note without controlling access is not a complete safety action.
Separate stock return from patient assessment
If a potentially affected product reached a patient, escalate through clinical and medication-safety processes. The notice describes potentially serious or fatal outcomes from inadvertent concentrated-potassium injection. Returning inventory does not replace patient review.
This is a dated educational case, not a live recall-status service. It does not declare all saline unsafe or tell an institution whether its recall is resolved. Check current notices, supplier communication and local records. Do not improvise potassium administration from packaging clues.
Use barcode checks as one defense, not the only defense
A barcode can accurately identify the label it scans while the contents disagree with that label. The recall illustrates why visible product inspection and a mismatch-escalation pathway still matter. Do not let one successful check silence contradictory evidence.
For practice, write what the scan proves and what it does not. Then separate the inventory action, communication to the responsible service and any patient-exposure review. Returning a bag solves a stock problem, not necessarily the clinical problem.
A worked case
The saline overwrap matches NDC 0990-7984-23, lot 1042188, but the inner bag says potassium chloride 10 mEq. The barcode scanned successfully.
- The overwrap matches the affected identifiers.
- The inner product reveals a medicine mismatch; the scan does not resolve it.
- Stop use, quarantine and escalate. Assess possible patient exposure separately.
Answer: A packaging-layer scan does not override the inner-product identity.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Does 100 mL size alone establish this recall?
No. Match the product, NDC and lot, and investigate mismatches independently.
2. Is stock return enough after possible patient exposure?
No. Clinical and medication-safety assessment is also needed.
3. Are all saline products unsafe because of this notice?
No. Do not generalize beyond the identified product/lot issue.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.